Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder

Bibliographic Details
Main Author: Andreas Bohle
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2010-08-01
Series:International Brazilian Journal of Urology
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000400024
id doaj-3698b2c89752462dbfb7e481c2659fc8
record_format Article
spelling doaj-3698b2c89752462dbfb7e481c2659fc82020-11-24T21:22:49ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-55381677-61192010-08-01364504517Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladderAndreas Bohlehttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000400024
collection DOAJ
language English
format Article
sources DOAJ
author Andreas Bohle
spellingShingle Andreas Bohle
Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
International Brazilian Journal of Urology
author_facet Andreas Bohle
author_sort Andreas Bohle
title Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
title_short Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
title_full Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
title_fullStr Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
title_full_unstemmed Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
title_sort long-term efficacy results of eortc genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus calmette-guérin, and bacillus calmette-guérin plus isoniazid in patients with intermediate- and high-risk stage ta t1 urothelial carcinoma of the bladder
publisher Sociedade Brasileira de Urologia
series International Brazilian Journal of Urology
issn 1677-5538
1677-6119
publishDate 2010-08-01
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000400024
work_keys_str_mv AT andreasbohle longtermefficacyresultsofeortcgenitourinarygrouprandomizedphase3study30911comparingintravesicalinstillationsofepirubicinbacilluscalmetteguerinandbacilluscalmetteguerinplusisoniazidinpatientswithintermediateandhighriskstagetat1urothelialcarcinomaofthebladd
_version_ 1725994562198962176